(Q46812278)

25 December 2017

title

Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy (English)

1 reference

25 December 2017

main subject

anti-retroviral agent

0 references

4

Dietmar Fuchs

1 reference

25 December 2017

Richard W Price

2

object named as

Richard W Price

1 reference

25 December 2017

Lars Hagberg

5

object named as

Lars Hagberg

1 reference

25 December 2017

Serena Spudich

3

object named as

Serena Spudich

1 reference

25 December 2017

author name string

Arvid Edén

1

1 reference

25 December 2017

Magnus Gisslén

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

25 December 2017

Journal of Infectious Diseases

published in

1 reference

25 December 2017

volume

196

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

1779-1783

1 reference

25 December 2017

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

cites work

1 reference

The neuropathogenesis of AIDS

21 January 2018

1 reference

Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients

21 January 2018

1 reference

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

21 January 2018

1 reference

Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.

21 January 2018

1 reference

Changing incidence of central nervous system diseases in the EuroSIDA cohort

21 January 2018

1 reference

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection

21 January 2018

1 reference

Antiretroviral treatment of central nervous system HIV-1 infection: a review

21 January 2018

1 reference

Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy

21 January 2018

1 reference

Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure

21 January 2018

1 reference

Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine

21 January 2018

1 reference

Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment

21 January 2018

1 reference

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

21 January 2018

1 reference

Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells

21 January 2018

1 reference

The two faces of HIV infection of cerebrospinal fluid

21 January 2018

1 reference

Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection

21 January 2018

1 reference

CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

21 January 2018

1 reference

Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1 infection.

21 January 2018

1 reference

Cerebrospinal fluid anti-cerebellar soluble lectin antibodies in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients

21 January 2018

1 reference

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

21 January 2018

1 reference

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

21 January 2018

1 reference

Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report

21 January 2018

1 reference

The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/523648

1 reference

25 December 2017

1 reference

25 December 2017